NCT03862677Recruiting
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
The IMPRoVE study is a prospective, non-interventional, explorative cohort study to determine prognostic immune markers in patients with epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer (EOC).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 26 Feb 2019
- Start date
- 15 Aug 2020
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Leiden University Medical Center
- Diseases
- Ovarian cancer
- NCT number
- NCT03862677
What you commit to
- Study type: Observational
- Planned participants: 300
- From 15 Aug 2020 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other active malignancy in past 5 years prior to entry into the study, except for treated non-melanoma skin cancer.
- Receiving immune suppressive treatment.
Other illness
- Any known severe infection like HIV, hepatitis A, B and C.
- Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.
Who the study is looking for
- Patients with (suspicion of) primary or recurrent EOC with an indication for surgery, chemotherapy and/or immunotherapy.
- Age ≥18 years.
- WHO performance status 0-2.
- Accessible for treatment and follow-up.
- Written informed consent.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Leiden University Medical Center Coordinator of this site? Confirm its status | Leiden | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.